These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10437291)

  • 1. [Recessive dopa-responsive form of dystonia due to a mutation of the tyrosine hydroxylase gene].
    Rondot P; Wevers RA
    Bull Acad Natl Med; 1999; 183(3):639-46; discussion 646-7. PubMed ID: 10437291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of dopa-responsive dystonia.
    Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
    Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia.
    Furukawa Y; Kapatos G; Haycock JW; Worsley J; Wong H; Kish SJ; Nygaard TG
    Ann Neurol; 2002 May; 51(5):637-41. PubMed ID: 12112113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine hydroxylase deficiency presenting with a biphasic clinical course.
    Giovanniello T; Leuzzi V; Carducci C; Carducci C; Sabato ML; Artiola C; Santagata S; Pozzessere S; Antonozzi I
    Neuropediatrics; 2007 Aug; 38(4):213-5. PubMed ID: 18058633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dopa-responsive dystonia (Segawa syndrome) with secondary skeleton deformity].
    Budrewicz SP; Góral M; Koszewicz M; Tarantowicz P; Podemski R
    Wiad Lek; 2006; 59(9-10):713-5. PubMed ID: 17338136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autosomal-dominant DOPA-responsive dystonia, caused by mutations in the GTP-cyclohydrolase I gene].
    Nagatsu T; Ichinose H
    Vopr Med Khim; 1998; 44(3):225-8. PubMed ID: 9703621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
    Furukawa Y
    Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia.
    Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA
    Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopa-responsive dystonia -- the story so far.
    Bandmann O; Wood NW
    Neuropediatrics; 2002 Feb; 33(1):1-5. PubMed ID: 11930268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segawa's disease: dopa-responsive dystonia.
    Gordon N
    Int J Clin Pract; 2008 Jun; 62(6):943-6. PubMed ID: 17971156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A homozygous tyrosine hydroxylase gene promoter mutation in a patient with dopa-responsive encephalopathy: clinical, biochemical and genetic analysis.
    Ribasés M; Serrano M; Fernández-Alvarez E; Pahisa S; Ormazabal A; García-Cazorla A; Pérez-Dueñas B; Campistol J; Artuch R; Cormand B
    Mol Genet Metab; 2007 Nov; 92(3):274-7. PubMed ID: 17698383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
    Bondarenko ES; Malyshev IuI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopa-responsive dystonia and Tourette syndrome in a large Danish family.
    Romstad A; Dupont E; Krag-Olsen B; Østergaard K; Guldberg P; Güttler F
    Arch Neurol; 2003 Apr; 60(4):618-22. PubMed ID: 12707079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
    Willemsen MA; Verbeek MM; Kamsteeg EJ; de Rijk-van Andel JF; Aeby A; Blau N; Burlina A; Donati MA; Geurtz B; Grattan-Smith PJ; Haeussler M; Hoffmann GF; Jung H; de Klerk JB; van der Knaap MS; Kok F; Leuzzi V; de Lonlay P; Megarbane A; Monaghan H; Renier WO; Rondot P; Ryan MM; Seeger J; Smeitink JA; Steenbergen-Spanjers GC; Wassmer E; Weschke B; Wijburg FA; Wilcken B; Zafeiriou DI; Wevers RA
    Brain; 2010 Jun; 133(Pt 6):1810-22. PubMed ID: 20430833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the clinical course, pathogenesis and treatment of torsion dystonia in childhood].
    Markova ED
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):32-5. PubMed ID: 2588895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical presentations of dopa-responsive dystonia.
    Bandmann O; Marsden CD; Wood NW
    Adv Neurol; 1998; 78():283-90. PubMed ID: 9750924
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia.
    de Yebenes JG; Moskowitz C; Fahn S; Saint-Hilaire MH
    Adv Neurol; 1988; 50():101-11. PubMed ID: 3400489
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase gene.
    Verbeek MM; Steenbergen-Spanjers GC; Willemsen MA; Hol FA; Smeitink J; Seeger J; Grattan-Smith P; Ryan MM; Hoffmann GF; Donati MA; Blau N; Wevers RA
    Ann Neurol; 2007 Oct; 62(4):422-6. PubMed ID: 17696123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics and biochemistry of dopa-responsive dystonia: significance of striatal tyrosine hydroxylase protein loss.
    Furukawa Y
    Adv Neurol; 2003; 91():401-10. PubMed ID: 12442699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.
    Furukawa Y; Kish SJ; Fahn S
    Ann Neurol; 2004 Jan; 55(1):147-8. PubMed ID: 14705130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.